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Introduction: Targeted temperature management (TTM) is recommended in the European Resuscita-
tion Council Guidelines for Post-resuscitation Care.1 However, previous studies report controversial 
results on the effect of TTM on platelet function (PF) in patients on dual antiplatelet therapy (DAPT) 
with aspirin and P2Y12 inhibitors. Hypothesis: To assess if the effect of DAPT on platelet inhibition in 
patients undergoing TTM for out-of-hospital cardiac arrest (OHCA) is reduced compared to patients on 
the same therapy not undergoing this procedure. 
Patients and Methods: Clinical characteristics and PF were 
analyzed in 56 consecutive patients admitted to the Depart-
ment of Cardiology at the University Hospital Centre between 
January 2012 and January 2019 under the diagnosis of acute 
myocardial infarction (AMI). Out of these 56 patients, 17 under-
went TTM to 34°C (Intervention group) while the other 39 did 
not (Control group). Both groups received the loading dose of 
DAPT. We analyzed residual PF using the Multiplate® PF ana-
lyzer ADP test. Platelet function tests (PFT) were performed 
18-24 hours after therapy initiation in both groups and 18-24 
hours after return to normal body temperature of 36.5° C in the 
TTM group. The control group had an average temperature of 
36.5° C at the time of the PFT. 
Results: There were 39 patients with a mean (SD) age of 63.2 
(9.9) years in the Control group and 17 patients with a mean 
(SD) age of 58.6 (8.2) in the Interventional group. There were 
no significant differences in the baseline parameters between 
the groups (history of IHD, hyperlipidemia, diabetes mellitus, 
smoking, gender, prior medical therapy, current medical ther-
apy). At the first time point (18-24 hours after initiating thera-
py) the intervention group had a significantly higher residual 
PF when compared to the control group (31.5 U vs 17.9 U; p<0.05). This difference is no longer present 
18-24 hours after return to normothermia (p=0.2) (Figure 1).
Conclusion: Our study shows that TTM decreases the effect of DAPT on PF in patients with AMI un-
dergoing TTM for OHCA. This is in line with the findings published by Uminska et al2 who showed that 
TTM severely decreases the bioavailability of P2Y12 inhibitors in this group of patients. These findings 
indicate that patients with AMI who experienced an OHCA undergoing TTM could have an impaired 
response to standard DAPT. 
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Figure 1. platelet function in the interventional (hypothermia) and 
control (normothermia) group.
NS = non-significant.
